We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Losmapimod Safety and Efficacy in COVID-19 (LOSVID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04511819
Recruitment Status : Terminated (Study terminated due to the rapidly evolving environment for the treatment of Covid-19 and ongoing challenges to identify and enroll qualified patients to participate.)
First Posted : August 13, 2020
Last Update Posted : April 4, 2022
Information provided by (Responsible Party):
Fulcrum Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 31, 2021
Actual Study Completion Date : March 31, 2021
Certification/Extension First Submitted : March 30, 2022